Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.
Published on: 2 Jun 2016
McGill Newsroom
McGill alumnus tagged to boost capacity and discovery in growing field
Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.
Category:
Published on: 27 May 2016
Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.
Category:
Published on: 24 May 2016
By Shawn Hayward, Montreal Neurological Institute and Hospital
Discovery will aid development of treatments for this debilitating disease
Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.
Published on: 10 May 2016
McGill University Health Centre
New study reinforces importance of implementing screening in Quebec
Published on: 4 May 2016
Discovery offers hope for more effective treatments of deadly glioblastomas
A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.
Category:
Published on: 25 Apr 2016
To support six research projects in fields from neuroscience to food safety and Arctic ecosystems
Category:
Published on: 15 Apr 2016
CREATE project to prepare graduates for high-skills work in surgical-devices industry
A team led by McGill University professor Jake Barralet will receive $1.65 million from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.
Published on: 14 Apr 2016
By Fergus Grieve, McGill Newsroom
Depression, metabolic factors combine to boost risk of developing diabetes, study finds
Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.
Published on: 12 Apr 2016
Published on: 11 Apr 2016
By Tod Hoffman, Lady Davis Institute
Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform
Published on: 8 Apr 2016
McGill University Health Centre
RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities
RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities
Category:
Published on: 31 Mar 2016
McGill, UCLA study of low- and middle-income countries shows paid maternity leave policies could help prevent infant deaths
For each additional month of paid maternity leave offered in low- and middle-income countries (LMICs), infant mortality is reduced by 13%, according to a new study by researchers from McGill University and UCLA Fielding School of Public Health.
Published on: 30 Mar 2016
McGill Newsroom
Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications
Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.
Published on: 24 Mar 2016
By Julie Robert, McGill University Health Centre
Millions of people today take statins to help lower their cholesterol level.
Category:
Published on: 11 Mar 2016
Pages
